Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Head Positioning on the Cross-sectional Area of the Subclavian Vein.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02860351
Recruitment Status : Completed
First Posted : August 9, 2016
Last Update Posted : April 10, 2017
Sponsor:
Information provided by (Responsible Party):
Jin-Young Hwang, SMG-SNU Boramae Medical Center

Brief Summary:
In the present study, the cross-sectional area of subclavian vein, the distances of subclavian vein ~ subclavian artery and subclavian vein ~ pleura are assessed in different head positions (neutral, rotation to ipsilateral or contralateral sides) in spontaneous breathing adults.

Condition or disease
Normal Volunteers

Layout table for study information
Study Type : Observational
Actual Enrollment : 42 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: The Effect of Head Positioning on the Cross-sectional Area of the Subclavian Vein
Study Start Date : August 10, 2016
Actual Primary Completion Date : March 10, 2017
Actual Study Completion Date : March 10, 2017

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Cross-sectional area of subclavian vein [ Time Frame: through study completion, an average of 1 year ]

Secondary Outcome Measures :
  1. depth of subclavian vein from skin [ Time Frame: through study completion, an average of 1 year ]
  2. Distance of subclavian vein ~ subclavian artery [ Time Frame: through study completion, an average of 1 year ]
  3. Distance of subclavian vein ~ pleura [ Time Frame: through study completion, an average of 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy adults ≥ 20 yr
Criteria

Inclusion Criteria:

  • Healthy adults

Exclusion Criteria:

  • Medication affecting vascular elasticity
  • History of central venous catheterization or clavicle fracture
  • History of lung surgery, operation of chest cage

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02860351


Locations
Layout table for location information
Korea, Republic of
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Seoul, Korea, Republic of, 156-707
Sponsors and Collaborators
SMG-SNU Boramae Medical Center
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Jin-Young Hwang, M.D, SMG-SNU Boramae Medical Center
ClinicalTrials.gov Identifier: NCT02860351    
Other Study ID Numbers: PRE20160711-001
First Posted: August 9, 2016    Key Record Dates
Last Update Posted: April 10, 2017
Last Verified: April 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Jin-Young Hwang, SMG-SNU Boramae Medical Center:
subclavian vein